赵静博士（Dr. Jing Zhao）
江苏集萃药康生物科技股份有限公司（江苏省产业技术研究院比较医学研究所）总经理
General manager of GemPharmatech Co., Ltd. (Institute of comparative medicine of JITRI)
赵静博士参与管理了国际小鼠表型分析联盟（IMPC）和中英泛素化项目（MADD）等国际大型合作项目，以及多个国家和省部级科技项目，包括国家重大科技专项、国家科技支撑计划、863和973等，项目经费总额超8500万元，横向合作项目总额超1亿。其中，研发项目“基因工程小鼠等相关疾病模型研发与应用”获得2015年国家教育部颁发的科技进步奖特等奖及2016年国务院颁发的国家科学技术进步奖二等奖，荣获创业南京高层次人才、南京市创新型企业家等殊荣。
Dr. Jing Zhao once participated in the management of many international large-scale cooperation projects such as the international mouse phenotype analysis Alliance (IMPC) and the Sino British ubiquitination project (MADD), as well as several national, provincial and ministerial science and technology projects, including national major science and technology projects, National Science and technology support plans, 863 project and 973 project. The total amount of project funds exceeded 85 million yuan and the total amount of horizontal cooperation projects exceeded 100 million yuan. Among them, the R & D project "R & D and application of genetic engineering mouse and other related disease models" won the special prize of science and technology progress award issued by the Ministry of education in 2015 and the second prize of national science and technology progress award issued by the State Council in 2016, and won the Awards of entrepreneurial Nanjing high-level talents and innovative entrepreneurs in Nanjing.
赵静博士有超过二十年的动物模型研发经验，主要研究领域为利用动物模型研究疾病的病理生理机制，精通ZFN、Talen、Cas9等基因编辑技术，在国际主流杂志Cell、Hum Mol Genet等发表SCI论文十余篇；同时精通实验动物国际化管理体系，有丰富的设施运行管理经验和质量控制经验，带领团队四次圆满通过国际AAALAC认证检查，确保产品线和服务体系符合规范化药物临床前实验检测对稳定性的要求。
Dr. Jing Zhao has more than 20 years experience in animal model research and development whose main research field is the pathophysiological mechanism of diseases using animal models. She is proficient in ZFN, talen, cas9 and other gene editing technologies and has published more than 10 SCI papers in international mainstream magazines such as cell and hum mol Genet; She is proficient in the international management system of experimental animals, has rich experience in facility operation management and quality control, and leads the team to successfully pass the international AAALAC certification inspection for four times to ensure that the product line and service system meet the stability requirements of standardized drug preclinical test.
Address:
Suzhou Dushu Lake Science and Education Innovation District
Suzhou Industrial Park
Suzhou
P.R.China
215123
江苏集萃药康生物科技股份有限公司（江苏省产业技术研究院比较医学研究所）总经理
General manager of GemPharmatech Co., Ltd. (Institute of comparative medicine of JITRI)
赵静博士参与管理了国际小鼠表型分析联盟（IMPC）和中英泛素化项目（MADD）等国际大型合作项目，以及多个国家和省部级科技项目，包括国家重大科技专项、国家科技支撑计划、863和973等，项目经费总额超8500万元，横向合作项目总额超1亿。其中，研发项目“基因工程小鼠等相关疾病模型研发与应用”获得2015年国家教育部颁发的科技进步奖特等奖及2016年国务院颁发的国家科学技术进步奖二等奖，荣获创业南京高层次人才、南京市创新型企业家等殊荣。
Dr. Jing Zhao once participated in the management of many international large-scale cooperation projects such as the international mouse phenotype analysis Alliance (IMPC) and the Sino British ubiquitination project (MADD), as well as several national, provincial and ministerial science and technology projects, including national major science and technology projects, National Science and technology support plans, 863 project and 973 project. The total amount of project funds exceeded 85 million yuan and the total amount of horizontal cooperation projects exceeded 100 million yuan. Among them, the R & D project "R & D and application of genetic engineering mouse and other related disease models" won the special prize of science and technology progress award issued by the Ministry of education in 2015 and the second prize of national science and technology progress award issued by the State Council in 2016, and won the Awards of entrepreneurial Nanjing high-level talents and innovative entrepreneurs in Nanjing.
赵静博士有超过二十年的动物模型研发经验，主要研究领域为利用动物模型研究疾病的病理生理机制，精通ZFN、Talen、Cas9等基因编辑技术，在国际主流杂志Cell、Hum Mol Genet等发表SCI论文十余篇；同时精通实验动物国际化管理体系，有丰富的设施运行管理经验和质量控制经验，带领团队四次圆满通过国际AAALAC认证检查，确保产品线和服务体系符合规范化药物临床前实验检测对稳定性的要求。
Dr. Jing Zhao has more than 20 years experience in animal model research and development whose main research field is the pathophysiological mechanism of diseases using animal models. She is proficient in ZFN, talen, cas9 and other gene editing technologies and has published more than 10 SCI papers in international mainstream magazines such as cell and hum mol Genet; She is proficient in the international management system of experimental animals, has rich experience in facility operation management and quality control, and leads the team to successfully pass the international AAALAC certification inspection for four times to ensure that the product line and service system meet the stability requirements of standardized drug preclinical test.
Contact information
Address:Suzhou Dushu Lake Science and Education Innovation District
Suzhou Industrial Park
Suzhou
P.R.China
215123
